ArticleClinical case reports2022

Clinical implications of combination therapy with quizartinib and craniospinal irradiation for refractory acute myeloid leukemia positive for FMS-like tyrosine kinase 3-internal tandem duplication with central nervous system involvement.

Makiko Suga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.